Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 2

1(25.0%)

4Total

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07539298Phase 2Not Yet Recruiting

Effects of VALsartan On atRIAl Mitral Regurgitation: A Pilot Randomized Controlled Trial

Role: collaborator

NCT07253805Active Not Recruiting

Plasma and Tissue Concentration of Cefazolin in Preoperative Prophylaxis in Patients Undergoing Bariatric Surgery

Role: collaborator

NCT02505074Unknown

Natural History of Melody Valve in the Mitral and Tricuspid Position

Role: collaborator

NCT04624191Not ApplicableUnknown

Clinical Impact of HOME Oxygen SATURation Measurement (SATURHOME)

Role: collaborator

NCT04658979Not ApplicableUnknown

Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study

Role: collaborator

NCT02492035Not ApplicableCompleted

Lifestyle Intervention for Treating Systemic Hypertension in Primary Care Setting

Role: collaborator

All 6 trials loaded